A growing coalition of epidemiologists and aerosol scientists say that improved ventilation could be a powerful tool against the coronavirus — if businesses are willing to invest the money.
Apr 26, 2022
Image
NICHOLAS KELLY WAS DIAGNOSED WITH CYSTIC FIBROSIS AS AN INFANT AND HAS NEVER BEEN HEALTHY ENOUGH TO WORK FULL TIME. HE WAS RECENTLY HOSPITALIZED FOR 2½ MONTHS DUE TO A LUNG INFECTION, A COMMON COMPLICATION FOR THE 30,000 AMERICANS WITH THIS DISEASE, MANY OF WHOM ARE BLACK AND/OR HISPANIC. ALTHOUGH NOVEL MEDICATIONS HAVE TRANSFORMED THE LIVES OF MOST PEOPLE WITH CF, THEY DON’T WORK IN 10% OF PATIENTS. “NOBODY WANTS TO BE HOSPITALIZED,” SAYS KELLY, WHO LIVES IN WILLOUGHBY, OHIO, A SUBURB OF CLEVELAND. “IF SOMETHING COULD DECREASE MY SYMPTOMS EVEN 10%, I WOULD TRY IT.”/KEN BLAZE FOR KHN
Patients with weakened immune systems, who are at high risk from COVID-19, say pharmacies are turning them away when they seek additional vaccine doses recommended by federal health officials.